Citation Impact
Citing Papers
The Hepatitis C Virus NS2/3 Protease
2007
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
2006
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
RNA-Guided Human Genome Engineering via Cas9
2013 StandoutScience
A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals
2008 StandoutNobel
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole
2006
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Novel therapeutic strategies targeting HIV integrase
2012
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
2011
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
2009
Synthesis and asymmetric hydrogenation of (3E)-1-benzyl-3-[(2-oxopyridin-1(2H)-yl)methylidene]piperidine-2,6-dione
2012
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation
1997
Synthetic biology: applications come of age
2010
Regulating Cell Surface Glycosylation by Small Molecule Control of Enzyme Localization
2003 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors
2009
Peptide dendrimers: applications and synthesis
2002
Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
1991
Recent advances in multiple antigen peptides
1996
Age-related macular degeneration
2012 Standout
Structure-Function Relationships Among RNA-Dependent RNA Polymerases
2007
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Hepatitis C Virus NS2 Protein Inhibits Gene Expression from Different Cellular and Viral Promoters in Hepatic and Nonhepatic Cell Lines
2003
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
The Hepatitis C Virus NS2 Protein Is an Inhibitor of CIDE-B-induced Apoptosis
2003
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
2008
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication
2005
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
The fluorenylmethoxycarbonyl group in solid phase synthesis
2003
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Subcellular targeting strategies for drug design and delivery
2009
Replication of hepatitis C virus
2007 StandoutNobel
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
3d Transition Metals for C–H Activation
2018 Standout
The Golden Age of Transfer Hydrogenation
2015 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
A dozen years of retro-inverso peptidomimetics
1993
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase
2003
The hepatitis C virus NS2/3 protease.
2007
Conditional Glycosylation in Eukaryotic Cells Using a Biocompatible Chemical Inducer of Dimerization
2008 StandoutNobel
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Seven Post-synthetic Covalent Reactions in Tandem Leading to Enzyme-like Complexity within Metal–Organic Framework Crystals
2016 StandoutNobel
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor
2012 StandoutNobel
Determinants of the Hepatitis C Virus Nonstructural Protein 2 Protease Domain Required for Production of Infectious Virus
2009 StandoutNobel
Polytryptophane terminated dendritic macromolecules
1991
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Dendrimers—Branching out from curiosities into new technologies
1998 StandoutNobel
Hepatitis C Virus NS2 Protein Is Phosphorylated by the Protein Kinase CK2 and Targeted for Degradation to the Proteasome
2005
Hepatitis C Virus Heteroduplex Tracking Assay for Genotype Determination Reveals Diverging Genotype 2 Isolates in Italian Hemodialysis Patients
1998 StandoutNobel
Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem
2010
Specificity of Acyl-Homoserine Lactone Synthases Examined by Mass Spectrometry
2005
Small-Molecule H-Bond Donors in Asymmetric Catalysis
2007 Standout
Conserved C-Terminal Threonine of Hepatitis C Virus NS3 Regulates Autoproteolysis and Prevents Product Inhibition
2003
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3
2009
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins
2003
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
CF2H, a Hydrogen Bond Donor
2017 Standout
Engineered bidirectional communication mediates a consensus in a microbial biofilm consortium
2007 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Fabio Bonelli being referenced
Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
2009
Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis
1995
Synthesis and biological evaluation of novel NK‐1 tachykinin receptor antagonists: The use of cycloalkyl amino acids as a template
1995
A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H‐2 haplotypes
1990
Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase
2009
Development of 2- butyl-N-methyl pyrimidones as potent inhibitors of HIV integrase
2008
Determination of the stoichiometry of noncovalent complexes using reverse-phase high-performance liquid chromatography coupled with electrospray ion trap mass spectrometry
2002
A novel, inducible, eukaryotic gene expression system based on the quorum‐sensing transcription factor TraR
2003
Should HCV RNA detection affect the isolation policy in dialysis units?
1994
Solid phase synthesis of retro‐inverso peptide analogues
1984
Large-scale production of peptides using the solid phase continuous flow method. Part 2: preparative synthesis of a 26-mer peptide thrombin inhibitor
1998
Large-scale production of peptides using the solid phase continuous flow method. Part 2cf. J. Peptide Sci. 3, 224–230 (1997) for part 1. : preparative synthesis of a 26-mer peptide thrombin inhibitor
1998
Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
2005
Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors
2007
Application of the continuous-flow polyamide method to the solid-phase synthesis of a multiple antigen peptide (MAP) based on the sequence of a malaria epitope
1990
Characterization of the Hepatitis C Virus NS2/3 Processing Reaction by Using a Purified Precursor Protein
2001
Potent Inhibitors of Subgenomic Hepatitis C Virus RNA Replication through Optimization of Indole-N-Acetamide Allosteric Inhibitors of the Viral NS5B Polymerase
2005